Obesity and worsening of chronic venous disease and joint mobility

Abstract

Objective

The aim of this study was to investigate a possible relationship between obesity and decreased mobility of the talocrural joint and in turn chronic venous disease.

Subjects and methods

One hundred obese patients recruited at Hospital Santa Casa de Maringa, Parana were enrolled by order of arrival at the hospital in a randomized quantitative cross-sectional study. Inclusion criteria were patients with a body mass index above 30 kg/m² and the exclusion criteria were infectious conditions that would interfere with the assessment. Patients were graded according to the clinical, etiological, anatomical and pathophysiological classification. Talocrural goniometry was performed to assess the degree of mobility of the legs. The Kolmogorov–Smirnov normality test, Kruskal–Wallis test, Dunn's Multiple comparison test and analysis of variance were used for statistical analysis tests with an alpha error of 5% being considered acceptable.

Results

The increase in body mass index is correlated to the reduction in joint mobility (Kruskal–Wallis test: p-value <0.0001) and increase in clinical, etiological, anatomical and pathophysiological classification is correlated to a decrease in joint mobility and the increase in age is associated with an increase in clinical, etiological, anatomical and pathophysiological classification (Kruskal–Wallis test: p-value <0.0001).

Conclusion

Obesity is associated with deterioration in joint mobility and worsening of chronic venous disease.

Keywords

Obesity mobility talocrural joint venous disease age

Introduction

Studies show that venous disease is more clinically severe in obese limbs and the venous reflux is worse. However, measurements of muscle pump function are better including the residual volumes and fractions, ambulatory venous pressure, venous filling index and the ejection volume. The foot venous pressure was significantly greater in the obese in all positions.¹

Another study shows that in about half of patients with unilateral varicosities, chronic venous disease (CVD) developed in the contralateral, initially asymptomatic, limb in five years. CVD progression consists in the development of reflux and clinical deterioration of the affected limbs. Obesity, orthostatism, and noncompliance with compression therapy are independent risk factors for CVD progression.²

There appears to be a relationship between obesity, CVD and popliteal venous compression. Popliteal vein compression syndrome may clarify the previously unexplained venous presentations. Surgical decompression provides good results in patients unresponsive to conservative treatment.³

Bilateral clinical manifestations of CVD are twice as common in the obese subset compared with the non-obese with the incidence increasing with body mass index (BMI). Resting and exercise femoral vein pressures were similar to the non-obese. Raju et al.⁴ reported that compression by increased intra-abdominal pressure associated with obesity is the likely mechanism of obstruction in 11% of limbs. Additionally, increasing the clinical, etiological, anatomical and pathophysiological (CEAP) classification is correlated with an increased mean BMI.⁵

The association of BMI with clinical severity independent of reflux measurements indicates that the effect of overweight may involve a mechanism separate from local effects on venous flow. Overweight appears to be a separate risk factor for increased severity of skin changes in patients with CVD.⁶ The aim of this study was to investigate a possible relationship between obesity and decreased mobility of the talocrural joint and in turn CVD.

Method

One hundred obese patients recruited at Hospital Santa Casa de Maringa, Parana were enrolled by order of arrival at the hospital in a randomized quantitative cross-sectional study.

Inclusion criteria were patients with a BMI above 30 kg/m² and the exclusion criteria were infectious conditions that would interfere in the assessment.

Patients were graded according to the CEAP classification: C0 (venous insufficiency – no varicose veins), C1 (telangiectasias – small varicose veins), C2 (varicose veins and edema), C4 (trophic changes), C5 (healed ulcer) and C6 (open sore). Talocrural goniometry was performed to assess the degree of mobility of the legs (range of ankle motion (ROAM)). The Kolmogorov–Smirnov normality test, Kruskal–Wallis test, Dunn's Multiple comparison test and analysis of variance were used for statistical analysis with an alpha error of 5% being considered acceptable.

The study was approved by the Research Ethics Committee of the institution and the Trial was registered – ACTRN12610000761066. (URL: http://www.ANZCTR.org.au/ACTRN12610000761066.aspx).

Results

This study recruited 100 patients of which 86% were females and 14% were males. The ages ranged from 18 to 68 years with an average age of 42 years and standard deviation of 12.4 years. The distribution of ages was approximately normal according to the Kolmogorov–Smirnov normality test (p-value = 0.4163). Table 1 shows that 63% of patients had Grade III obesity or morbid obesity (BMI greater than 40.0 kg/m²), 29% Grade II obesity (BMI between 35.0 and 39.9 kg/m²) and only 8% had Grade I obesity (BMI between 30.0 and 34.9 kg/m²). The mean BMI was 42.3 kg/m² with a standard deviation of 5.2 kg/m² (range: 31.1 kg/m² to 58.1 kg/m²). The Kolmogorov–Smirnov normality test shows that the pattern of BMIs has approximately a normal distribution (p-value = 0.887). Table 2 shows that the most common CEAP classification (30%) for the right leg of participants was C1, i.e. the patients had telangiectasias (small varicose veins), while for the left leg the most common was CEAP C2 (36%), that is, patients with varicose veins. Tables 3 and 4 show the ROAM in degrees of the right and left legs of patients. The distribution of the ROAM of the right and left legs is approximately normal according to the Kolmogorov–Smirnov normality test (p-values = 0.2763 and 0.1423, respectively).

Table 1.

BMI (kg/m²) of patients.

BMI	Number	Percentage
30 to 35	8	8.0
35 to 40	29	29.0
40 or more	63	63.0
Total	100	100.0

Table 2.

Distribution of CEAP classifications.

CEAP	Right	Left	Total	Percentage
C0	12	9	21	10.5
C1	30	20	50	25.0
C2	28	36	64	32.0
C3	25	25	50	25.0
C4	5	10	15	7.5
C5	–	–	–	–
C6	–	–	–	–
Total	100	100	200	100

Table 3.

ROAM in degrees of the right leg.

ROAM (°)	Total	Percentage
8 to 16	8	8.0
16 to 24	18	18.0
24 to 32	34	34.0
32 to 40	17	17.0
40 to 48	10	10.0
48 to 56	10	10.0
56 or more	3	3.0
Total	100	100.0

Table 4.

ROAM in degrees of the left leg.

ROAM (°)	Total	Percentage
9 to 17	7	7.0
17 to 25	25	25.0
25 to 33	31	31.0
33 to 41	19	19.0
41 to 49	11	11.0
49 to 57	5	5.0
57 or more	2	2.0
Total	100	100.0

The increase in BMI is correlated to the reduction in joint mobility (Kruskal–Wallis test: p-value <0.0001 – Figure 1). The increase in CEAP is correlated to a decrease in joint mobility and the increase in age is associated with an increase in CEAP (Kruskal–Wallis test: p-value <0.0001 – Figure 2).

Figure 1.

The increase in BMI is correlated to the reduction in joint mobility (Kruskal–Wallis test: p-value <0.0001).

Figure 2.

The increase in CEAP is correlated to a decrease in joint mobility and the increase in age is associated with an increase in CEAP (Kruskal–Wallis test: p-value <0.0001).

Analysis of variance was used to check whether there are differences in the mean BMIs of patients in respect to the CEAP classification of both legs. This analysis showed that there is a significant difference (p-value <0.001) between the CEAP classifications, that is, the classifications are different between legs.

The Box-plot graph in Figure 3 shows that the CEAP classification increases as the BMI increases and the box-plot graph in Figure 4 shows that the BMI may not correlate to the CEAP classification of both right and left legs.

Figure 3.

Box-Plot of BMI according to the CEAP.

Figure 4.

Box-Plot of BMI according to the CEAP classifications of the right and left legs.

Discussion

This study demonstrates that there is a reduction in joint mobility with increases with BMI and the CEAP classification and an increase in the CEAP classification with increased BMI and age.

Therefore, we suggest that there is an impairment of the suction-impulse pumps in obesity, which is exacerbated with aging and the deterioration of CEAP. We believe the aspiration-impulsion pump is functionally well; however, the increased abdominal pressure in obese patients may compromise its effectiveness. Further studies are necessary to try to test this theory.

The worsening of joint mobility may influence the contractile mechanisms of the suction-impulse pumps, but the study found no impairment in pump function.¹ This may be associated with the degree of impairment of joint mobility. A study evaluating joint mobility and the clinical stages of CEAP identified that in later stages, the C5 and C6 classifications of CEAP, hemodynamic changes occur as can be seen by plethysmography and joint mobility.^7,8 In this study, no patients were in these stages, stages in which the talocrural joint mobility could be further undermined.

Among the pathophysiological mechanisms proposed is external compression of both intra-abdominal and popliteal veins.^3,4 One study suggests that lower limb venous flow parameters differ significantly between healthy obese and non-obese individuals. These findings support the mechanical role of abdominal adipose tissue potentially leading to elevated risk for both venous thromboembolism and chronic venous insufficiency.⁹ The pump is working, but the intra-abdominal resistance may limit its efficacy. Another aggravating factor is standing for long periods and failure to use protective devices such as compression garments.²

Associations between obesity and erysipelas¹⁰ have been described; this also contributes to aggravating lymphatic system diseases and may worsen fibrosis and the lack of joint mobility.

Studies describe that there are many elements associated to this complex condition of CVD, for example, microvascular dysfunction, calf muscle pump efficiency, dermal inflammation; disordered fibroblast function and matrix production; failure of epithelialization, congenital and acquired thrombophilia, malnutrition, obesity and diet; and bacterial colonization.¹¹ This association may contribute to aggravate the disease.

None of the currently available treatment modalities is entirely satisfactory and novel therapies based upon a clearer understanding of the disease at the psychological, genetic, mechanical, microvascular and microscopic level are required.

Conclusion

Obesity is associated with deterioration in joint mobility and worsening of CVD.

Footnotes

Acknowledgements

The authors wish to thank Dr. Hugo Partsh for his suggestions in the text and his contribution to the statistical analysis.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not for-profit sectors.

Conflict of interest

None declared.

References

van Rij

De Alwis

Jiang

. Obesity and impaired venous function. Eur J Vasc Endovasc Surg 2008; 35: 739–744.

Kostas

Ioannou

Drygiannakis

. Chronic venous disease progression and modification of predisposing factors. J Vasc Surg 2010; 51: 900–907.

Lane

Cuzzilla

Harris

. Popliteal vein compression syndrome: obesity, venous disease and the popliteal connection. Phlebology 2009; 24: 201–207.

Raju

Darcey

Neglén

. Iliac-caval stenting in the obese. J Vasc Surg 2009; 50: 1114–1120.

Padberg

Jr Cerveira

Lal

. Does severe venous insufficiency have a different etiology in the morbidly obese? Is it venous? J Vasc Surg 2003; 37: 79–85.

Danielsson

Eklof

Grandinetti

. The influence of obesity on chronic venous disease. Vasc Endovascular Surg 2002; 36: 271–276.

Cavalheri

Jr de Godoy

Belczak

. Correlation of haemodynamics and ankle mobility with clinical classes of clinical, aetiological, anatomical and pathological classification in venous disease. Phlebology 2008; 23: 120–124.

Pereira de Godoy

Braile

de Fátima Guerreiro Godoy

. Lymph drainage in patients with joint immobility due to chronic ulcerated lesions. Phlebology 2008; 23: 32–34.

Willenberg

Schumacher

Amann-Vesti

. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg 2010; 52: 664–668.

10.

Pereira de Godoy

Galacini Massari

Yoshino Rosinha

. Epidemiological data and comorbidities of 428 patients hospitalized with erysipelas. Angiology 2010; 61: 492–494.

11.

Bradbury

. Epidemiology and aetiology of C4-6 disease. Phlebology 2010; 25(Suppl 1): 2–8.